Skip to content
healthcare.dev

Diltiazem hydrochloride

NDC 70771-1932, Diltiazem hydrochloride, tablet, from Zydus Lifesciences Limited.

Product NDC
70771-1932
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219253
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1932 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DILTIAZEM HYDROCHLORIDE120 mg/1

Pharmacologic classes

Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A4 Inhibitors [MoA]

Package NDCNDC-11Package
70771-1932-170771193201100 TABLET in 1 BOTTLE (70771-1932-1)
70771-1932-570771193205500 TABLET in 1 BOTTLE (70771-1932-5)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8329d0ac-d68c-48d2-9cbc-e1a1b60192d9

Use it

Look up 70771-1932 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1932 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1932. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.